Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action
about
Dissociation of the trimeric gp41 ectodomain at the lipid–water interface suggests an active role in HIV-1 Env-mediated membrane fusionHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.Complete dissociation of the HIV-1 gp41 ectodomain and membrane proximal regions upon phospholipid bindingInsights into the Conformation of the Membrane Proximal Regions Critical to the Trimerization of the HIV-1 gp41 Ectodomain Bound to Dodecyl Phosphocholine Micelles.The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance.Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure.Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides.Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length.Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41.Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition.A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity.Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.Sequence-selective DNA recognition and enhanced cellular up-take by peptide-steroid conjugates.
P2860
Q27681827-AE550B1E-902E-4968-8491-C4D6672D6DDAQ27692605-9F1EB397-A7FE-4897-993C-CC577A99F997Q30601090-CD92F028-AB2E-4CD1-9F1D-21095B8382C2Q34517381-F064BB70-CCD5-4C0A-A830-7471B5A8AD46Q35434452-48FF4894-C7A0-409E-8F4B-30770B90EACFQ36101299-5BF199FB-C8D5-4C8C-A7CA-8F94C82B07B4Q36282554-64CBC263-6CF6-4A60-B8BD-82DD7712C8CFQ37688270-DE85949B-0ACE-4178-A827-9FF0F9DFEF11Q37715076-28D44A58-84CF-4DDF-ACE6-A5E3F5AF6408Q38675925-634565A5-2B7C-4BF3-BD63-C31F90AD405BQ38992313-8574831E-0D72-4F64-B550-3622E2AE4A32Q40141950-13D1D7A2-032C-44AA-BB1A-E1CF6D764045Q40267838-28B45C00-F764-4EB7-A1C4-C634D02AF73FQ47582990-3004AC52-F65F-411C-B017-B70803F7C7ECQ49105554-D80500BF-ADA3-40AD-A27C-975E0E067A1C
P2860
Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Conjugation of cholesterol to ...... ctions potentiating its action
@ast
Conjugation of cholesterol to ...... ctions potentiating its action
@en
Conjugation of cholesterol to ...... ctions potentiating its action
@nl
type
label
Conjugation of cholesterol to ...... ctions potentiating its action
@ast
Conjugation of cholesterol to ...... ctions potentiating its action
@en
Conjugation of cholesterol to ...... ctions potentiating its action
@nl
prefLabel
Conjugation of cholesterol to ...... ctions potentiating its action
@ast
Conjugation of cholesterol to ...... ctions potentiating its action
@en
Conjugation of cholesterol to ...... ctions potentiating its action
@nl
P2860
P50
P3181
P1433
P1476
Conjugation of cholesterol to ...... ctions potentiating its action
@en
P2093
Miguel A R B Castanho
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0060302
P407
P577
2013-04-02T00:00:00Z